limestone has been researched along with Kidney Failure, Chronic in 216 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 54 (25.00) | 18.7374 |
| 1990's | 58 (26.85) | 18.2507 |
| 2000's | 63 (29.17) | 29.6817 |
| 2010's | 39 (18.06) | 24.3611 |
| 2020's | 2 (0.93) | 2.80 |
| Authors | Studies |
|---|---|
| Fujikawa, K; Hiroyoshi, T; Isoyama, N; Kuro-O, M; Matsuyama, H; Miura, Y; Nagata, Y; Nakamura, K | 1 |
| Ardissino, G; Brancadoro, A; Capone, V; Cropanese, I; Grimaldi, E; Groppelli, A; Leoni, A; Margiotta, E; Matta, R; Messa, P; Montini, G; Patricelli, M; Pavone, L; Raffiotta, F; Vettoretti, S | 1 |
| Bosch, J; Gao, P; Garg, AX; Girard, L; Manns, BJ; Mazzetti, A; Parfrey, P; Rabbat, CG; Rathe-Skafel, A; Smyth, A; Tennankore, K; Tyrwhitt, J; Wald, R; Walsh, M; Yan, AT | 1 |
| Furui, H; Gotoh, J; Hattori, M; Horie, T; Iida, J; Kawamura, A; Kukita, K; Meguro, J; Onodera, K; Tamaki, T; Tsuchihashi, S; Yonekawa, M | 1 |
| Hasegawa, Y; Kamo, Y; Kikuchi, N; Matsuda, E; Sekino, H; Sekino, M; Takeuchi, K | 1 |
| Hong, Z; Ishizu, T; Kaneko, Y; Matsunaga, T; Taru, Y | 1 |
| Burnier, M; Funk, F; Maillard, M; Mordasini, D; Peregaux, C; Phan, O; Stehle, JC | 1 |
| Ahn, SE; Choi, JI; Han, DS; Jeon, YC; Kim, HS; Lee, YH; Yi, JH | 1 |
| Mattu, M; Yarlagadda, SG | 1 |
| Galani, VJ; Prajapati, VA; Shah, PR | 1 |
| Fukuda, M; Ikeda, Y; Kishi, T; Miyazono, M; Nonaka, Y; Sanai, T; Sato, S; Takashima, T; Yoshizaki, M | 1 |
| Hara, K; Kishi, Y; Kurosawa, N; Obara, Y; Takada, D; Yamashiro, H | 1 |
| Fukumitsu, T; Ono, T; Sanai, T; Tada, H | 1 |
| Bell, C; Bellasi, A; Cipriani, F; Di Iorio, B; Molony, D; Ruggeri, M; Russo, D | 1 |
| Kitazono, T; Noguchi, H; Ooboshi, H; Tatsumoto, N; Tokumoto, M; Tsuruya, K; Yamada, S | 1 |
| Marano, M | 1 |
| Bigazzi, R; Casani, A; Di Giorgio, A; Grazi, G; Manca Rizza, G; Migliori, M; Panichi, V; Paoletti, S; Rosati, A; Ruggeri, M; Scatena, A; Sgambato, A | 1 |
| Biyani, M; Imtiaz, R; Lavoie, S; Leung, S; McCormick, B; Wagner, J; Zimmerman, D | 1 |
| Huang, CC; Lin, HH; Liou, HH; Wu, MS | 1 |
| Abu-Ghazaleh, D; Al-Ramahi, R; Bsharat, A; Raddad, AR; Rashed, AO; Shehab, O; Yasin, E | 1 |
| Matsuda, H; Miyazaki, M; Oka, Y | 1 |
| Afshan, S; Echols, V; Farah Musa, AR; Fülöp, T; Lerant, AA | 1 |
| Shigematsu, T | 1 |
| Hori, K; Izumi, M; Kasumoto, H; Kitamura, R; Miyamoto, T; Morita, S; Nakanishi, T; Nishian, Y; Oue, M; Yamamoto, S | 1 |
| De Vos, JY; Elseviers, M | 1 |
| Alonso, M; Andrés, E; Ballarín, J; Bover, J; Canal, C; Farré, N; Olaya, MT; Quílez, B | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Khan, DA; Khan, FA; Saif, I | 1 |
| Fan, Q; Liu, J; St Peter, WL; Weinhandl, E | 1 |
| Curran, MP; Robinson, DM | 1 |
| Chew, D; Kidder, AC | 1 |
| Rees, L; Shroff, RC | 1 |
| Assimon, MM; Mousa, S; Pai, AB; Shaker, O | 1 |
| Barré, P; Hercz, G; Hirsch, D; Hodsman, A; Leblanc, M; Levin, A; Lok, C; Morton, AR; Murphy, S; Reslerova, M | 1 |
| Cardinal, H; Mailhot, M; Ouellet, G; Roy, L; Ste-Marie, LG | 1 |
| Noto, L | 1 |
| Block, GA; Langman, CB; Moe, SM | 1 |
| Elashoff, R; Gales, B; Jüppner, H; Pereira, RC; Sahney, S; Salusky, IB; Wang, HJ; Wesseling-Perry, K | 1 |
| Fukagawa, M; Hirawa, N; Hyodo, T; Kakuta, T; Kanai, G; Kobayashi, H; Miyata, T; Nagaoka, M; Oogushi, Y; Saito, A; Suzuki, H; Takahashi, H; Tanaka, R | 1 |
| Damment, SJ | 1 |
| Anstey, CM; Gray, NA; Hollett, PR; Krishnasamy, R; Vardesh, DL | 1 |
| Negi, S; Shigematsu, T | 1 |
| Aldridge, B; Chen, NX; Chen, X; Gattone, VH; Moe, SM; Radcliffe, JS; Seifert, MF; White, KE | 1 |
| Jean, G | 1 |
| Martínez, AI; Milán, JA; Salgueira, M | 1 |
| Carroll, R; Cervelli, MJ; McDonald, SP; Meade, A; Shaman, A | 1 |
| Bigliati, M; D'Ippolito, P; Pierantozzi, M; Zatelli, A; Zini, E | 1 |
| Acharya, L; Acharya, S; Adhikary, L | 1 |
| Choi, HY; Lee, HY; Lee, YK; Shin, SK | 1 |
| Ávila-Díaz, M; Cisneros, A; Cueto-Manzano, A; García-López, E; Gómez, AM; Hinojosa-Heredia, H; Lindholm, B; Méndez-Duran, A; Obrador, GT; Paniagua, R; Trinidad, P; Ventura, MD | 1 |
| Gwi, E; Lo, KY; Mak, SK; Tong, GM; Wong, AK; Wong, PN | 1 |
| Bijak, K; Bogdańska-Straszyńska, B; Matuszkiewicz-Rowińska, J; Małecka, G; Ostrowski, K; Przedlacki, J; Trebicka, J | 1 |
| Cleveland, M | 1 |
| Castro, R; Ferreira, C; Herman, A; Nunes-Azevedo, J; Oliveira, M; Travassos, F | 1 |
| Bahloul, H; Boitte, F; Brazier, M; El Esper, I; El Esper, N; Fournier, A; Mazouz, H; Moriniere, P; Oprisiu, R; Sadek, T | 1 |
| Balducci, A; Coen, G; Curic, S; D'Haese, PC; De Broe, ME; Dimkovic, N; Djukanovic, L; Ferreira, A; Freemont, TJ; Hutchison, A; Pejanovic, S; Popovic, M; Sikole, A; Spasovski, GB; Sulkova, S; Sulowicz, W; Swanepoel, C; Torres, A | 1 |
| Amor, J; Aresté, N; Cambil, T; Gómez, O; Páez, C; Palma, A; Salgueira, M; Sánchez-Palencia, R | 1 |
| Bleyer, AJ | 1 |
| Alhejaili, F; Clement, L; Heidenheim, AP; Kortas, C; Leitch, R; Lindsay, RM; Nesrallah, G | 1 |
| Akiba, T; Kabaya, T; Kawashima, A; Nihei, H; Nitta, K; Uchida, K; Yumura, W | 1 |
| Bommer, J; Chertow, GM; Raggi, P | 1 |
| Fukui, M; Hamada, C; Hayashi, K; Ishiguro, C; Koizumi, M; Osada, S; Sakamoto, T; Shou, I; Tomino, Y | 1 |
| Akeel, NM; Badawi, LS; Shaheen, FA; Souqiyyeh, MZ | 1 |
| Asmus, HG; Bommer, J; Braun, J; Brunkhorst, R; Holzer, H; Krause, R; Neumayer, HH; Raggi, P; Schulz, W | 1 |
| Hoshino, J; Takaichi, K; Ubara, Y | 1 |
| Tominaga, Y | 1 |
| Bofinger, A; Burke, JR; Campbell, SB; Hawley, CM; Isbel, NM; Johnson, DW; Reiger, K; Sturtevant, JM | 1 |
| Benador, N; Greenbaum, LA; Grenda, R; Melnick, JZ; Paredes, A; Qiu, P; Restaino, I; Salusky, IB; Williams, LA; Wojtak, A | 1 |
| Kinugasa, E; Koiwa, F; Ogata, H; Shishido, K | 1 |
| Ito, K; Izumi, M; Matsumoto, A; Miyamoto, T; Nakagawa, K; Nakanish, T; Shirai, K; Takamitsu, Y; Takenaka, Y; Yamanashi, T | 1 |
| Fukagawa, M; Kurihara, T; Kurosawa, T; Nishi, H; Sato, T | 1 |
| Cantor, T; Rees, L; Ridout, D; Waller, SC | 1 |
| Abdrachmanovas, O; Kuzminskis, V; Ryselis, S; Skarupskiene, I; Smalinskiene, A | 1 |
| Fukagawa, M; Kato, H; Koiwa, F; Okada, T; Onoda, N; Shigematsu, T; Tokumoto, A | 1 |
| Goto, H; Goto, Y; Iwasaki, Y; Shigematsu, T; Takami, H; Tani, M; Yamaguchi, Y | 1 |
| Inaba, M; Nishizawa, Y; Shoji, T; Tabata, T; Tahara, H; Tsujimoto, Y | 1 |
| Asmus, G; Backs, W; Hutchison, AJ; Jamar, R; Maes, B; Mohamed, E; Schmieder, R; Vanwalleghem, J; Vosskühler, A | 1 |
| Bito, Y; Fujita, Y; Kasumoto, H; Komaba, K; Nishioka, M; Shibuya, K; Shin, J; Shinko, S; Yamamoto, T | 1 |
| Inaba, M; Nishizawa, Y; Shouji, T; Tabata, T; Tahara, H; Tsujimoto, Y | 1 |
| Denton, J; Freemont, AJ; Hoyland, JA | 1 |
| Chicella, MF; Dice, JE; Storms, LE | 1 |
| Abu-Alfa, AK; Brewster, UC; Ciampi, MA; Reilly, RF | 1 |
| Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
| Bellasi, A; Block, GA; Galassi, A; Raggi, P; Spiegel, DM | 1 |
| Rees, L; Ridout, D; Waller, S | 1 |
| Orita, H; Sakaguchi, T; Shigematsu, T | 1 |
| Andreucci, VE; Battaglia, Y; Buonanno, E; Manzi, S; Miranda, I; Ruocco, C; Russo, D; Russo, L; Scafarto, A | 1 |
| Barroso, S; Caravaca, F; Cerezo, I; Escola, JM; Fernández, N; Hernández Gallego, R; Martín, MV; Ruiz, AB | 1 |
| Chasseraud, M; Drüeke, TB; Ivanovski, O; Joki, N; Lacour, B; Louvet, L; Maizel, J; Massy, ZA; Nguyen-Khoa, T; Nikolov, IG; Phan, O | 1 |
| Borzecki, AM; Brenner, L; Kazis, LE; Lee, A; Wang, SW | 1 |
| Suki, WN | 1 |
| Kagia, S; Kallivretakis, NE; Oreopoulos, DG; Papadaki, AN; Spadidakis, VV; Tzanakis, IP; Wei, M | 1 |
| Baldaia, J; Duggal, A; Ferreira, A; Frazão, JM; Galvao, J; Gil, C; Hoenger, RM; Malluche, HH; Monier-Faugere, MC; Oliveira, C; Ribeiro, S; Rodrigues, I; Santos, C | 1 |
| Chaplin, S; Elgazzar, HA; Goldsmith, D; Molony, DA; Taylor, MJ | 1 |
| Date, T; Funakoshi, S; Hashiguchi, J; Itoh, K; Kono, T; Kubo, H; Masaki, K; Nakano, H; Shigematsu, T; Tanaka, M; Uchino, J | 1 |
| Harland, C; Wrong, O | 1 |
| Akiba, T; Kabaya, T; Matsugami, K; Mimuro, T; Nitta, K; Otsubo, S; Takei, T; Uchida, K | 1 |
| Franklin, SS; Gordon, A; Kleeman, CR; Maxwell, MH | 1 |
| Barsotti, G; Cristofano, C; Giovannetti, S; Lupetti, S; Meola, M; Morelli, E | 1 |
| Afanas'eva, GA; Babarykin, DA; Luse, LIa; Rozental', RL; Shul'man, OM | 1 |
| Mehls, O; Ritz, E | 1 |
| Harter, H; Horst, R; Martin, KJ; Slatopolsky, E; Thielan, J; Weerts, C | 1 |
| Chocianowicz, H; Młotkowska, E; Snarska, J; Sulima-Gillow, A | 1 |
| Walser, M | 1 |
| Aparicio, M; Blanchetier, V; Bouchet, JL; Combe, C; de Précigout, V; Fournier, A; Morel, D; Potaux, L | 1 |
| Tsukamoto, Y | 1 |
| Concepcion, MT; De Bonis, E; Felsenfeld, AJ; Gonzalez-Posada, JM; Hernandez, D; Lorenzo, V; Martinez, ME; Rodriguez, A; Rodriguez, M; Torres, A | 1 |
| Fournier, A | 1 |
| Armstrong, A; Cunningham, J | 1 |
| Izumida, I; Morishita, T; Moriya, R; Nagaba, Y; Okubo, M; Tsukamoto, Y | 1 |
| Nakamura, M; Ohishi, A; Ohno, Y; Okada, H; Saruta, T; Suzuki, H; Yamakawa, H | 1 |
| Henderson, IS; Jones, MC; McElduff, N; Pflanz, S | 1 |
| Bianchi, ML; Buccianti, G; Campanini, F; Colantonio, G; Ortolani, S; Rossi, R; Valenti, G | 1 |
| Passlick-Deetjen, J; Ritz, E; Weinreich, T | 1 |
| Davenport, A; Goel, S; Mackenzie, JC | 1 |
| Almaraz-Jimenez, M; Gomez-Fernandez, P; Perez-Mijares, R; Ramos-Diaz, M; Rivero-Bohorquez, J | 1 |
| Ali, AA; Baillod, RA; Moorhead, JF; Sweny, P; Varghese, Z | 1 |
| Goldsmith, DJ | 1 |
| Brown, CB | 1 |
| Briggs, JD; Harden, PN; Junor, BJ; Rodger, RS; Rowe, PA; Spooner, RJ; Tan, CC | 1 |
| Adu, D; Bhalla, C; Cochrane, T; Duncan, R; Michael, J; Richards, NT | 1 |
| Roszkowska-Blaim, M; Sieniawska, M; Wojciechowska, B | 1 |
| Barreneche, M; Graciela Garcia, M; Leanza, H; Najun Zarazga, C | 1 |
| Delmez, JA; Giles, KS; Kelber, J; Norword, KY; Slatopolsky, E | 1 |
| El Esper, N; Fournier, A; Moriniere, P; Oprisiu, R | 1 |
| Argilés, A; Mion, C; Mourad, G | 1 |
| Janssen, MJ; ter Wee, PM; van Boven, WP; van der Kuy, A | 1 |
| Kokot, FS; Kolonko, A; Wiecek, A; Wystrychowski, A | 1 |
| Corradi, B; Imbasciati, E; Malberti, F | 1 |
| Schaefer, K | 1 |
| Leu, ML; Lin, JL | 1 |
| Novikov, AI | 1 |
| Franson, KL; Kuk, JM; Lau, AH | 1 |
| Barsotti, G; Barsotti, M; Cozza, V; Cupisti, A; Giovannetti, S; Meola, M; Morelli, E | 1 |
| Argilés, A; Lorho, R; Mourad, G | 1 |
| Alderman, JM; Meyer-Stout, PJ; Stamatakis, MK | 1 |
| Bleyer, AJ; Burke, SK; Chertow, GM; Dillon, M; Domoto, DT; Garrett, BN; Slatopolsky, E; Steg, M; Wilkes, BM; Wombolt, DG | 1 |
| Kessler, M | 1 |
| Marc n, R; Orofino, L; Ortuño, J; Rivera, M; Rodríguez, JR; Tenorio, MT; Teruel, JL | 1 |
| Fukagawa, M | 1 |
| Abighanem, O; Brazier, M; Fournier, A; Morinière, P; Rasombololona, M; Said, S; Séchet, A | 1 |
| Goto, S; Miura, Y; Moriya, H; Nakano, H; Nishimura, M; Saisu, T; Shigematsu, T; Wakabayashi, Y; Yamada, K | 1 |
| Brophy, DF; Gehr, TW; Holdford, DA; Kennedy, DT; Wallace, JF | 1 |
| Llach, F; Yudd, M | 1 |
| Chen, JS; Chen, PY; Chen, WY; Chung Wu, D; Huang, CL; Huang, JW; Hung, KY; Kan, YT; Lee, SH; Leu, LJ; Yang, CS | 1 |
| d'Almeida Filho , EJ; da Cruz, EA; Hoette, M; Keen, LN; Lugon, JR; Ruzany, F | 1 |
| Collin, P; Houssin, A; Riberi, P; Spiesser, R; Touzard, D | 1 |
| Ikeda, H; Sasaki, Y; Shioji, R; Ueda, H | 1 |
| Ardaillou, R; Fillastre, JP; Isaac, R; Nivez, MP; Piamba, G | 1 |
| Grönhagen-Riska, C; Honkanen, E; Ikäheimo, R; Kala, AR | 1 |
| Groshong, T; Lal, SM | 1 |
| Macon, EJ; Oettinger, CW; Oliver, JC | 1 |
| Barsotti, G; Cupisti, A; Giovannetti, S | 1 |
| Nakazawa, R | 1 |
| Björck, S; Delin, K; Wilske, J | 1 |
| Hatano, M; Nagura, Y; Okada, K; Takahashi, S | 2 |
| Mörsky, P; Mustonen, J; Pasternack, A; Pietilä, K; Reinikainen, P; Saha, H; Seppälä, E | 1 |
| Bdolah-Abram, T; Ben-Ezer, D; Chaimovitz, C; Conforty, A; Edelstein, S; Kafka, DR; Rapoport, J; Shany, S | 1 |
| Laurinová, Z; Sulková, S; Válek, A | 1 |
| Godley, PJ; Wasan, SM | 1 |
| Mayo, M; Middleton, RK | 1 |
| Makoff, R | 1 |
| Fitzrandolph, RL; Molpus, WM; Pritchard, RS; Walker, CW | 1 |
| Foley, J; Goodman, WG; Nelson, P; Salusky, IB | 1 |
| Gladziwa, U; Ittel, TH; Schäfer, C; Schmitt, H; Sieberth, HG | 1 |
| Cupisti, A; Giovannetti, S; Guidi, A | 1 |
| Hisano, S; Kawagoe, M; Ueda, K; Yamane, I | 1 |
| Günther, K; Kirchner, E; Marzoll, I; Sperschneider, H; Stein, G | 1 |
| Bia, MJ; Meric, F; Yap, P | 1 |
| Henderson, IS; Mactier, RA; Stewart, WK; Taylor, JE | 1 |
| Martis, L; Nolph, KD; Serkes, KD | 1 |
| Chantler, C; Clark, AG; Haycock, GB; Oner, A; Rigden, SP; Turner, C; Ward, G | 1 |
| O'Nunan, T; Vennegoor, M; Walls, J; Williams, B | 1 |
| Brinn, NT; Proia, AD | 1 |
| Goldstein, SJ; Kobrin, SM; Raja, RM; Shangraw, RF | 1 |
| Delmez, J; Finch, J; Fryer, P; Giles, K; Norwood, K; Slatopolsky, E; Weerts, C; Windus, D | 1 |
| Barsotti, G; Giovannetti, S; Gretz, N; Kraft, K | 1 |
| Fujishima, M; Motomura, K; Okuda, S; Onoyama, K; Sanai, T | 1 |
| Emmett, M; Fordtran, JS; Mai, ML; Santa Ana, CA; Schiller, L; Sheikh, MS | 1 |
| Oliver, DO; Raine, AE | 1 |
| Emmett, M; Fordtran, JS; Maguire, JA; Nicar, MJ; Santa Ana, CA; Schiller, LR; Sheikh, MS | 1 |
| Belbrik, S; Boudaillez, B; Fournier, A; Hocine, C; Marie, A; Moriniere, P; Renaud, H; Westeel, PF | 1 |
| Malberti, F; Minoia, C; Poggio, F; Salvadeo, A; Surian, M | 1 |
| Chantler, C; Haycock, GB; Mak, RH; Rigden, SP; Start, KM; Tamanaha, K; Turner, C | 1 |
| Fujita, T; Fukase, M; Koishi, M; Nakada, M | 1 |
| Hatano, M; Kuno, T; Maeda, H; Okada, K; Takahashi, S; Yanai, M | 1 |
| Gaspari, F; Locatelli, M; Remuzzi, G; Viganò, G | 1 |
| Chantler, C; Compston, J; Haycock, GB; Mak, RH; Mellish, RW; Turner, C; Vedi, S | 1 |
| Fournier, A; Morinière, P; Renaud, H | 1 |
| Deuber, HJ; Schulz, W | 1 |
| Fijałkowska, A; Krzemień, G; Lewicki, Z; Makarewicz, W; Rośzkowska-Blaim, M; Sieniawska, M | 1 |
| Keogh, B; McParland, C; O'Brien, A | 1 |
| Delmez, J; Slatopolsky, E; Stokes, T; Weerts, C; Windus, D | 1 |
| Audet, P; Fallon, MD; Kaplan, F; Morrison, G; Shusterman, NH; Wasserstein, AG | 1 |
| Delmez, J; Lopez-Hilker, S; Norwood, K; Slatopolsky, E; Weerts, C; Windus, D; Zink, M | 1 |
| Leumann, EP | 1 |
| Blockey, NJ; Mocan, H; Murphy, AV | 1 |
| Emmett, M; Fathi, N; Fordtran, JS; Morawski, SG; Ramirez, JA; Santa Ana, CA; White, MG | 1 |
| Alon, U; Bentur, L; Berant, M; Better, OS; Davidai, G | 1 |
| Andreoli, SP; Bergstein, JM; Dunson, JW | 1 |
| Chantler, C; Haycock, GB; Mak, RH; Powell, H; Thompson, T; Turner, C | 1 |
| Ginsburg, DS; Kaplan, EL; Katz, AI | 1 |
| Guerre, J; Matuchansky, C; Péquignot, H | 1 |
| Renner, E | 1 |
| Halgrimson, CG; Hutt, MP; Pinggera, WF; Popovtzer, MM; Robinette, J; Starzl, TE | 1 |
| Marsac, J; Meyrier, A; Richet, G | 1 |
| Bordier, PJ; Clarkson, EM; de Wardener, HE; Eastwood, JB; Tun Chot, S | 1 |
| Piper, DW | 1 |
| Meyrier, A; Richet, G; Verger, D | 1 |
| Bordier, P; de Wardener, HE; Eastwood, JB | 1 |
| Berlyne, GM | 1 |
| Clarkson, EM; De Wardener, HE; McDonald, SJ | 1 |
26 review(s) available for limestone and Kidney Failure, Chronic
| Article | Year |
|---|---|
Update on the treatment of chronic kidney disease-mineral and bone disorder.
Topics: Aluminum Compounds; Calcinosis; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet, Protein-Restricted; Dietetics; Humans; Kidney Failure, Chronic; Lanthanum; Naphthalenes; Nephrology; Nutrition Assessment; Nutritive Value; Parathyroidectomy; Patient Care Team; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Sevelamer; Vitamin D | 2009 |
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
Lanthanum carbonate: a review of its use in lowering serum phosphate in patients with end-stage renal disease.
Topics: Administration, Oral; Adult; Animals; Calcium Carbonate; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Time Factors | 2009 |
Treatment options for hyperphosphatemia in feline CKD: what's out there?
Topics: Animals; Calcium Carbonate; Cat Diseases; Cats; Chelating Agents; Diet; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Phosphorus; Prognosis | 2009 |
Phosphate binders in CKD: chalking out the differences.
Topics: Calcium; Calcium Carbonate; Child; Diet; Humans; Hyperparathyroidism; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Vascular Diseases | 2010 |
The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Clinical Trials as Topic; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Polyamines; Renal Dialysis; Sevelamer | 2010 |
[How to manage mineral metabolism disorders in renal failure].
Topics: Aged; Alkaline Phosphatase; Bone Density; Calcimimetic Agents; Calcitriol; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Combined Modality Therapy; Diabetic Nephropathies; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus, Dietary; Predictive Value of Tests; Renal Replacement Therapy | 2011 |
Phosphate binder usage in kidney failure patients.
Topics: Acetates; Aluminum Compounds; Calcium Carbonate; Calcium Compounds; Clinical Trials as Topic; Epoxy Compounds; Humans; Iron Compounds; Ketoglutaric Acids; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
[Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].
Topics: Calcinosis; Calcium; Calcium Carbonate; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Epoxy Compounds; Evidence-Based Medicine; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Polyamines; Polyethylenes; Practice Guidelines as Topic; Sevelamer | 2004 |
[Clinical practice guidelines for severe renal hyperparathyroidism].
Topics: Biomarkers; Calcium Carbonate; Diagnostic Imaging; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Phosphorus Metabolism Disorders; Practice Guidelines as Topic; Severity of Illness Index; Thyroid Gland; Transplantation, Autologous | 2004 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
[Phosphate binder up to date].
Topics: Aluminum Hydroxide; Calcium Carbonate; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Sevelamer | 2007 |
Pathophysiology and treatment of secondary hyperparathyroidism in patients with chronic renal failure.
Topics: Administration, Oral; Animals; Calcitriol; Calcium Carbonate; Diet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone | 1995 |
The treatment of metabolic bone disease in patients on peritoneal dialysis.
Topics: Aluminum Compounds; Bone Diseases, Metabolic; Calcium Carbonate; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Uremia; Vitamin D | 1994 |
Oral vitamin D or calcium carbonate in the prevention of renal bone disease?
Topics: Administration, Oral; Animals; Bone Diseases; Calcium; Calcium Carbonate; Cholecalciferol; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Phosphates; Renal Dialysis | 1996 |
[Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)].
Topics: Aluminum Hydroxide; Antacids; Calcitriol; Calcium; Calcium Carbonate; Diet; Dose-Response Relationship, Drug; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Renal Dialysis | 1997 |
[Chronic renal failure: etiology, physiopathology, diagnosis, principles of the treatment].
Topics: Adolescent; Adult; Age Factors; Antihypertensive Agents; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Creatinine; Diagnosis, Differential; Diet; Female; Humans; Infant; Infant, Newborn; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Male; Peritoneal Dialysis; Renal Dialysis; Sex Factors; Water-Electrolyte Balance | 1998 |
[Physiopathology and therapy of renal osteodystrophy and secondary hyperparathyroidism].
Topics: Animals; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Parathyroidectomy; Receptors, Calcitriol; Vitamin D | 1999 |
Current medical management of secondary hyperparathyroidism.
Topics: Acetates; Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Intestinal Absorption; Kidney Failure, Chronic; Magnesium Compounds; Parathyroid Hormone; Parathyroidectomy; Phosphates; Phosphorus, Dietary | 2000 |
The metabolic acidosis of chronic renal failure: pathophysiology and treatment.
Topics: Acidosis; Bicarbonates; Calcium Carbonate; Diet; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic | 1992 |
Phosphate binders in hyperphosphatemia of chronic renal failure.
Topics: Aluminum Hydroxide; Calcium Carbonate; Citrates; Citric Acid; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Renal Dialysis | 1991 |
Calcium carbonate in hyperphosphatemia.
Topics: Acidosis; Aluminum Hydroxide; Calcium Carbonate; Humans; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Renal Dialysis | 1991 |
The value of calcium carbonate in treating acidosis, phosphate retention, and hypocalcemia.
Topics: Acidosis; Calcium Carbonate; Clinical Protocols; Humans; Hypocalcemia; Kidney Failure, Chronic; Phosphorus Metabolism Disorders | 1991 |
The radiographic spectrum of renal osteodystrophy.
Topics: Aluminum Hydroxide; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Kidney Failure, Chronic; Phosphates; Radiography | 1991 |
Calcium carbonate as a phosphate binder: is there a need to adjust peritoneal dialysate calcium concentrations for patients using CaCO3?
Topics: Calcium; Calcium Carbonate; Dialysis Solutions; Humans; Hypercalcemia; Intestinal Absorption; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulatory; Phosphates | 1989 |
1,25 (OH)2 vitamin D3 deficiency and renal osteodystrophy: should its well-accepted pathogenetic role in secondary hyperparathyroidism lead to its systematic preventive therapeutic use?
Topics: Calcitriol; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Vitamin D Deficiency | 1987 |
55 trial(s) available for limestone and Kidney Failure, Chronic
| Article | Year |
|---|---|
The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; alpha-2-HS-Glycoprotein; Calcium; Calcium Carbonate; Drug Substitution; Female; Fibroblast Growth Factor-23; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Prospective Studies; Renal Dialysis | 2020 |
Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.
Topics: Aged; Biomarkers; Calcium Carbonate; Canada; Chelating Agents; Drug Dosage Calculations; Drug Monitoring; Feasibility Studies; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Nomograms; Phosphates; Pilot Projects; Quality of Life; Renal Dialysis; Time Factors; Treatment Outcome | 2017 |
Study of prolonged administration of lanthanum carbonate in dialysis patients.
Topics: Aged; Calcium; Calcium Carbonate; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Time Factors; Treatment Outcome | 2013 |
Three-year follow-up of lanthanum carbonate therapy in hemodialysis patients.
Topics: Adult; Aged; Calcium; Calcium Carbonate; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Vitamin D | 2013 |
Efficacy of continuous oral administration of lanthanum carbonate over 24 months.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Calcium; Calcium Carbonate; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Medication Adherence; Middle Aged; Parathyroid Hormone; Phosphates; Polyamines; Practice Guidelines as Topic; Prospective Studies; Renal Dialysis; Sevelamer; Time Factors | 2013 |
Clinical effects of long-term (36-month) lanthanum carbonate administration in hemodialysis patients in Japan.
Topics: Aged; Calcium; Calcium Carbonate; Chelating Agents; Dose-Response Relationship, Drug; Female; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Time Factors; Treatment Outcome | 2014 |
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study.
Topics: Aged; Antacids; Calcium Carbonate; Chelating Agents; Cost of Illness; Cost-Benefit Analysis; Female; Humans; Hyperphosphatemia; Italy; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Sevelamer; Treatment Outcome | 2015 |
Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort study.
Topics: Administration, Oral; Calcium Carbonate; Chelating Agents; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Phosphates; Prospective Studies; Treatment Outcome | 2015 |
Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients.
Topics: Aged; alpha-2-HS-Glycoprotein; C-Reactive Protein; Calcium; Calcium Carbonate; Chelating Agents; Cholesterol, LDL; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Sevelamer; Treatment Outcome; Triglycerides | 2016 |
Multicenter prospective randomized, double-blind comparative study between lanthanum carbonate and calcium carbonate as phosphate binders in Japanese hemodialysis patients with hyperphosphatemia.
Topics: Antacids; Calcium Carbonate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis; Treatment Outcome | 2008 |
Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cost-Benefit Analysis; Drug Costs; Follow-Up Studies; Health Care Costs; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Medicaid; Medicare; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome; United States | 2009 |
Does concomitant administration of sevelamer and calcium carbonate modify the control of phosphatemia?
Topics: Aged; Calcium Carbonate; Chelating Agents; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.
Topics: Adolescent; Bone and Bones; Bone Density Conservation Agents; Calcitriol; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Ergocalciferols; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Longitudinal Studies; Male; Osteogenesis; Parathyroid Hormone; Polyamines; Sevelamer | 2011 |
Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.
Topics: Calcinosis; Calcium Carbonate; Chelating Agents; Chromatography, High Pressure Liquid; Coronary Artery Disease; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Treatment Outcome | 2011 |
Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Biomarkers; Calcium; Calcium Carbonate; Chelating Agents; Cross-Over Studies; Cross-Sectional Studies; Double-Blind Method; Drug Interactions; Female; Gastric Acid; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Pantoprazole; Parathyroid Hormone; Phosphates; Proton Pump Inhibitors; Renal Dialysis; South Australia; Time Factors; Treatment Outcome | 2012 |
Effect of lanthanum carbonate on phosphate control in continuous ambulatory peritoneal dialysis patients in Korea: a randomized prospective study.
Topics: Adult; Calcium; Calcium Carbonate; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Prospective Studies; Republic of Korea | 2013 |
Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study.
Topics: Adjuvants, Immunologic; Antacids; Calcium; Calcium Carbonate; Dialysis Solutions; Drug Therapy, Combination; Epoxy Compounds; Follow-Up Studies; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism; Kidney Failure, Chronic; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Time Factors | 2003 |
A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients.
Topics: Adult; Aged; Biomarkers; Bone and Bones; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis | 2003 |
[Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
Topics: Aged; Calcifediol; Calcitriol; Calcium; Calcium Carbonate; Calcium, Dietary; Chelating Agents; Chelation Therapy; Creatinine; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Treatment Outcome | 2003 |
Calcium and phosphate balance with quotidian hemodialysis.
Topics: Adult; Aged; Alkaline Phosphatase; Appointments and Schedules; Calcium; Calcium Carbonate; Female; Follow-Up Studies; Hemodialysis Solutions; Hemodialysis, Home; Humans; Hyperparathyroidism, Secondary; Isoenzymes; Kidney Failure, Chronic; Male; Middle Aged; Ontario; Parathyroid Hormone; Phosphates; Prospective Studies; Treatment Outcome | 2003 |
Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
Topics: Acetates; Aortic Valve; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Heart Valve Diseases; Humans; Kidney Failure, Chronic; Mitral Valve; Multivariate Analysis; Renal Dialysis; Tomography, X-Ray Computed | 2004 |
Efficacy and safety of sevelamer. Comparison with calcium carbonate in the treatment of hyperphosphatemia in hemodialysis patients.
Topics: Adult; Analysis of Variance; Calcium Carbonate; Chi-Square Distribution; Cross-Over Studies; Epoxy Compounds; Female; Humans; Kidney Failure, Chronic; Male; Phosphorus Metabolism Disorders; Polyamines; Polyethylenes; Prospective Studies; Renal Dialysis; Sevelamer; Treatment Outcome | 2004 |
Long-term comparison of a calcium-free phosphate binder and calcium carbonate--phosphorus metabolism and cardiovascular calcification.
Topics: Adult; Calcinosis; Calcium Carbonate; Cardiovascular Diseases; Epoxy Compounds; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Time Factors | 2004 |
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Topics: Acetates; Adolescent; Calcitriol; Calcium; Calcium Carbonate; Calcium Channel Agonists; Calcium Compounds; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Renal Dialysis | 2005 |
Control of parathyroid function in patients with a short history of hemodialysis.
Topics: Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Female; Follow-Up Studies; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Time Factors | 2005 |
Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan.
Topics: Analysis of Variance; Calcium Carbonate; Chi-Square Distribution; Drug Therapy, Combination; Female; Humans; Japan; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Treatment Outcome | 2005 |
Efficacy of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients.
Topics: Calcium Carbonate; Chi-Square Distribution; Drug Therapy, Combination; Female; Humans; Japan; Kidney Failure, Chronic; Male; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Statistics, Nonparametric; Treatment Outcome | 2005 |
Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study.
Topics: Adult; Aged; Calcium; Calcium Carbonate; Female; Follow-Up Studies; Humans; Hypercalcemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis; Treatment Outcome | 2006 |
[Clinical effect of introduction of sevelamer hydrochloride in patients with hyperphosphatemia undergoing maintenance dialysis].
Topics: Biomarkers; Calcium; Calcium Carbonate; Dialysis; Drug Therapy, Combination; Humans; Kidney Failure, Chronic; Lipids; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Sevelamer | 2005 |
The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Calcitriol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Failure, Chronic; Lanthanum; Male; Phosphorus; Renal Dialysis; Treatment Outcome | 2005 |
Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders.
Topics: Acetates; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Coronary Vessels; Diabetes Mellitus; Female; Humans; Hypoparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2006 |
Bone mineral density in children with chronic renal failure.
Topics: Absorptiometry, Photon; Adolescent; Bone Density; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Child; Child, Preschool; Cohort Studies; Female; Glomerular Filtration Rate; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates | 2007 |
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial.
Topics: Adult; Aged; Calcium Carbonate; Calcium Compounds; Cause of Death; Chelating Agents; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Patient Selection; Phosphate-Binding Proteins; Polyamines; Renal Dialysis; Sevelamer | 2008 |
Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial.
Topics: Alkaline Phosphatase; Calcium; Calcium Carbonate; Follow-Up Studies; Humans; Kidney Failure, Chronic; Magnesium; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Reference Values; Renal Dialysis; Treatment Outcome | 2008 |
Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.
Topics: Adult; Aged; Antacids; Biopsy; Calcification, Physiologic; Calcium; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Ilium; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2008 |
Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Topics: Adult; Aged; Calcium; Calcium Carbonate; Chelating Agents; Drug Therapy, Combination; Epichlorohydrin; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Imidazoles; Japan; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Resins, Synthetic; Sevelamer | 2008 |
Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
Topics: Aged; Analysis of Variance; Aorta, Abdominal; Aortic Diseases; Biomarkers; C-Reactive Protein; Calcinosis; Calcium; Calcium Carbonate; Chelating Agents; Disease Progression; Female; Humans; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Severity of Illness Index; Statistics, Nonparametric; Tomography, X-Ray Computed | 2008 |
Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure.
Topics: Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors | 1995 |
Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis.
Topics: Acetates; Acetic Acid; Adult; Aged; Calcium; Calcium Carbonate; Cross-Over Studies; Drug Tolerance; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Patient Compliance; Phosphates; Renal Dialysis | 1994 |
Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
Topics: Alkaline Phosphatase; Aluminum Hydroxide; Bone Density; Calcitriol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Prospective Studies; Time Factors | 1995 |
Ranitidine reduces phosphate binding in dialysis patients receiving calcium carbonate.
Topics: Adult; Aged; Calcium Carbonate; Cross-Over Studies; Double-Blind Method; Female; Gastric Juice; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Ranitidine; Renal Dialysis | 1996 |
Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study.
Topics: Adult; Aged; Binding Sites; Calcitriol; Calcium; Calcium Carbonate; Cross-Over Studies; Drug Administration Routes; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Dialysis | 1996 |
Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Topics: Acetates; Acetic Acid; Aluminum Hydroxide; Calcium Carbonate; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Patient Compliance; Phosphates; Prospective Studies; Renal Dialysis; Time Factors | 1996 |
Calcium carbonate can enhance aluminium absorption from aluminium hydroxide in patients with impaired renal function.
Topics: Adult; Aluminum; Aluminum Hydroxide; Calcium Carbonate; Humans; Intestinal Absorption; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1996 |
Phosphate-binding capacities of calcium and aluminum formulations.
Topics: Acetates; Administration, Oral; Adult; Aluminum Compounds; Calcium Carbonate; Calcium Phosphates; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Monitoring; Female; Gels; Humans; Intestinal Absorption; Kidney Failure, Chronic; Male; Phosphates; Suspensions; Tablets | 1998 |
Secondary hyperparathyroidism in severe chronic renal failure is corrected by very-low dietary phosphate intake and calcium carbonate supplementation.
Topics: Adult; Aged; Amino Acids; Antacids; Apolipoproteins B; Calcium; Calcium Carbonate; Cholesterol; Creatinine; Diet, Protein-Restricted; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus, Dietary; Triglycerides; Urea; Vitamin D | 1998 |
A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients.
Topics: Calcium; Calcium Carbonate; Cholesterol; Female; Gels; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Sevelamer | 1999 |
[Role of the time of administration of calcium carbonate (before or during mealtime) in the control of hyperphosphatemia in patients on maintenance hemodialysis].
Topics: Aged; Bicarbonates; Calcium; Calcium Carbonate; Cross-Over Studies; Drug Administration Schedule; Eating; Fasting; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates; Renal Dialysis | 1999 |
Calcium acetate versus calcium carbonate in the control of hyperphosphatemia in hemodialysis patients.
Topics: Acetates; Adult; Analysis of Variance; Antacids; Calcium Carbonate; Cross-Over Studies; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus Metabolism Disorders; Renal Dialysis | 2000 |
Oral administration of 24,25(OH)2D3 suppresses the serum parathyroid hormone levels of dialysis patients.
Topics: 24,25-Dihydroxyvitamin D 3; Administration, Oral; Aged; Calcium Carbonate; Dose-Response Relationship, Drug; Humans; Kidney Failure, Chronic; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory | 1991 |
Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease.
Topics: Adolescent; Adult; Aluminum; Aluminum Hydroxide; Antacids; Bone Diseases; Calcium Carbonate; Child; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Phosphates; Prospective Studies; Random Allocation; Renal Dialysis | 1991 |
Calcium carbonate as a phosphate binder in dialysis patients: evaluation of an enteric-coated preparation and effect of additional aluminium hydroxide on hyperaluminaemia.
Topics: Aluminum; Aluminum Hydroxide; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Hypercalcemia; Kidney Failure, Chronic; Kidney Function Tests; Parathyroid Hormone; Phosphates; Prospective Studies; Renal Dialysis; Tablets | 1991 |
Calcium acetate, an effective phosphorus binder in patients with renal failure.
Topics: Acetates; Acetic Acid; Adult; Calcium Carbonate; Female; Humans; Intestinal Absorption; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis | 1989 |
The absorption of dietary phosphorus and calcium in hemodialysis patients.
Topics: Adult; Aged; Aluminum Hydroxide; Antacids; Calcitriol; Calcium Carbonate; Calcium, Dietary; Female; Humans; Intestinal Absorption; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis | 1986 |
Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide.
Topics: Adolescent; Aluminum Hydroxide; Calcium Carbonate; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Random Allocation | 1985 |
135 other study(ies) available for limestone and Kidney Failure, Chronic
| Article | Year |
|---|---|
Calcium carbonate-enriched cheese to improve nutrition, compliance and phosphorus control in patients on kidney replacement therapy.
Topics: Calcium; Calcium Carbonate; Cheese; Cross-Over Studies; Double-Blind Method; Humans; Kidney Failure, Chronic; Phosphorus; Quality of Life; Renal Dialysis | 2022 |
PA21, a new iron-based noncalcium phosphate binder, prevents vascular calcification in chronic renal failure rats.
Topics: Adenine; Animals; Aorta; Blood Pressure; Calcium; Calcium Carbonate; Ferric Compounds; Fibroblast Growth Factors; Heart Rate; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus; Rats; Rats, Wistar; Vascular Calcification | 2013 |
[A case of isolated small intestinal wall calcification on patient with continuous ambulatory peritoneal dialysis].
Topics: Calcinosis; Calcitriol; Calcium; Calcium Carbonate; Calcium Channel Agonists; Humans; Intestine, Small; Kidney Failure, Chronic; Male; Mesenteric Artery, Superior; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Tomography, X-Ray Computed | 2013 |
Metastatic calcifications after parathyroidectomy in a dialysis patient.
Topics: Calcinosis; Calcium Carbonate; Chelating Agents; Dietary Supplements; Humans; Hypocalcemia; Kidney Failure, Chronic; Male; Multiple Pulmonary Nodules; Parathyroidectomy; Renal Dialysis; Tomography, X-Ray Computed; Young Adult | 2013 |
A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
Topics: Acetates; Adult; Biomarkers; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Time Factors; Treatment Outcome | 2014 |
A comparison of the long-term effects of lanthanum carbonate and calcium carbonate on the course of chronic renal failure in rats with adriamycin-induced nephropathy.
Topics: Animals; Blood Pressure; Calcium Carbonate; Disease Models, Animal; Doxorubicin; Glucuronidase; Kidney Failure, Chronic; Kidney Function Tests; Klotho Proteins; Lanthanum; Male; Rats; Time Factors | 2014 |
Phosphate binders and metabolic acidosis in patients undergoing maintenance hemodialysis—sevelamer hydrochloride, calcium carbonate, and bixalomer.
Topics: Acidosis; Calcium Carbonate; Chelating Agents; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Renal Dialysis; Sevelamer | 2015 |
Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Topics: Adenine; Animal Feed; Animals; Calcinosis; Calcium Carbonate; Cellular Senescence; Disease Models, Animal; Disease Progression; Fibrosis; Immunohistochemistry; Inflammation; Kidney; Kidney Failure, Chronic; Lanthanum; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Phosphates; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Signal Transduction; Uremia; Vascular Calcification | 2015 |
Phosphate binders and metabolic acidosis.
Topics: Acidosis; Calcium Carbonate; Chelating Agents; Female; Humans; Kidney Failure, Chronic; Male; Polyamines; Renal Dialysis | 2015 |
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study.
Topics: Acetates; Aged; C-Reactive Protein; Calcium Carbonate; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Cost-Benefit Analysis; Databases, Factual; Female; Humans; Kidney Failure, Chronic; Male; Markov Chains; Middle Aged; Phosphates; Prospective Studies; Quality-Adjusted Life Years; Renal Dialysis; Sevelamer; Stroke; Survival Analysis; Vitamin D | 2015 |
Evaluation of potential drug- drug interactions among Palestinian hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Arabs; Aspirin; Calcium Carbonate; Comorbidity; Diabetes Mellitus; Drug Interactions; Drug Prescriptions; Female; Gout; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Middle East; Polypharmacy; Renal Dialysis; Retrospective Studies; Risk Factors | 2016 |
Did Lanthanum Carbonate Improve Prognosis in Patients Requiring Chronic Hemodialysis in the Kawashima Study?
Topics: Calcium Carbonate; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Prognosis; Renal Dialysis | 2016 |
Persisting Hypocalcemia After Surgical Parathyroidectomy: The Differential Effectiveness of Calcium Citrate Versus Calcium Carbonate With Acid Suppression.
Topics: Adult; Calcium Carbonate; Calcium Citrate; Drug Interactions; Humans; Hypocalcemia; Kidney Failure, Chronic; Male; Parathyroidectomy; Proton Pump Inhibitors; Renal Dialysis | 2017 |
Switching from calcium carbonate to sevelamer hydrochloride has suppressive effects on the progression of aortic calcification in hemodialysis patients: assessment using plain chest X-ray films.
Topics: Aged; Antacids; Aortic Diseases; Calcinosis; Calcium Carbonate; Chelating Agents; Disease Progression; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Radiography, Thoracic; Renal Dialysis; Retrospective Studies; Sevelamer | 2008 |
The use of phosphate binders: data from contributors to the European Practice Database.
Topics: Acetates; Aluminum Compounds; Analysis of Variance; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cross-Sectional Studies; Databases, Factual; Dietetics; Drug Utilization; Europe; Health Care Surveys; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Nephrology; Polyamines; Practice Patterns, Physicians'; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2009 |
Assessment of bone mineral metabolism derangements by K/DOQI guidelines in haemodialysis patients at Rawalpindi.
Topics: Acetates; Adult; Aged; Bone and Bones; Bone Diseases, Metabolic; Calcium; Calcium Carbonate; Calcium Compounds; Female; Guideline Adherence; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pakistan; Parathyroid Hormone; Phosphates; Practice Guidelines as Topic; Renal Dialysis | 2009 |
Development and utility of a multi-dimensional grid to assess individual mineral metabolism control in hemodialysis patients: A potential aid for therapeutic decision making?
Topics: Aged; Aluminum Hydroxide; Calcium; Calcium Carbonate; Chelating Agents; Decision Making; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Minerals; Parathyroid Hormone; Phosphates; Polyamines; Prevalence; Quality Control; Renal Dialysis; Reproducibility of Results; Retrospective Studies; Sevelamer | 2010 |
Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Carbonate; Calcium Compounds; Chelating Agents; Humans; Kidney Failure, Chronic; Lanthanum; Middle Aged; New York; Nutritional Status; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Serum Albumin; Sevelamer; Treatment Outcome | 2011 |
Oral phosphate binders in patients with kidney failure.
Topics: Calcium Carbonate; Chelating Agents; Humans; Kidney Failure, Chronic; Phosphates | 2010 |
Pharmacology of the phosphate binder, lanthanum carbonate.
Topics: Aluminum Hydroxide; Animals; Calcium; Calcium Carbonate; Chelating Agents; Dogs; Drug Evaluation, Preclinical; Feces; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Mice; Phosphates; Phosphorus Radioisotopes; Polyamines; Rats; Rats, Sprague-Dawley; Sevelamer | 2011 |
Impact of non-traditional phosphate binders and cinacalcet on haemodialysis patient biochemistry, pill burden and cost.
Topics: Administration, Oral; Aged; Aged, 80 and over; Aluminum Hydroxide; Australia; Calcitriol; Calcium Carbonate; Chelating Agents; Cinacalcet; Drug Costs; Female; Health Care Costs; Hemodialysis Units, Hospital; Humans; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2011 |
Combined therapy with lanthanum carbonate and calcium carbonate for hyperphosphatemia decreases serum FGF-23 level independently of calcium and PTH (COLC Study).
Topics: Adult; Aged; Antacids; Calcium; Calcium Carbonate; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Prospective Studies; Renal Dialysis; Treatment Outcome; Young Adult | 2012 |
The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.
Topics: Animals; Bone Diseases; Calcification, Physiologic; Calcium Carbonate; Gene Expression Regulation; Kidney Failure, Chronic; Male; Organ Specificity; Polyamines; Rats; Reverse Transcriptase Polymerase Chain Reaction; Sevelamer | 2011 |
Regression of vascular calcification in a patient treated with cinacalcet: a case report.
Topics: Breast; Calcimimetic Agents; Calcitriol; Calcium Carbonate; Chelating Agents; Cinacalcet; Drug Therapy, Combination; Female; Graft Rejection; Hand; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Mammography; Middle Aged; Naphthalenes; Nephritis, Interstitial; Phosphorus; Polyamines; Renal Dialysis; Reoperation; Sevelamer; Vascular Calcification | 2011 |
Effect of dietary supplements in reducing probability of death for uremic crises in dogs affected by chronic kidney disease (masked RCCT).
Topics: Animals; Calcium Carbonate; Chi-Square Distribution; Chitosan; Citric Acid; Creatinine; Dietary Supplements; Dog Diseases; Dogs; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Potassium Citrate; Random Allocation; Survival Rate; Treatment Outcome; Uremia | 2012 |
Role of CaCO3 alone and CaCO3 plus vitamin D3 in terms of calcium phosphorus product in chronic kidney diseases.
Topics: Adult; Antacids; Calcium; Calcium Carbonate; Cholecalciferol; Cross-Sectional Studies; Drug Therapy, Combination; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nepal; Phosphorus; Prospective Studies; Renal Dialysis; Vitamins | 2011 |
Reaching targets for mineral metabolism clinical practice guidelines and its impact on outcomes among Mexican chronic dialysis patients.
Topics: Adult; Calcium; Calcium Carbonate; Cohort Studies; Diabetes Mellitus; Female; Humans; Kidney Failure, Chronic; Male; Mexico; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Risk Factors; Survival Rate; Treatment Outcome | 2013 |
Tumoral calcinosis after an injection of recombinant human erythropoietin in a dialysis patient.
Topics: Administration, Oral; Adult; Bursa, Synovial; Calcinosis; Calcium; Calcium Carbonate; Dialysis Solutions; Erythropoietin; Female; Glomerulonephritis, IGA; Humans; Hypercalcemia; Hyperplasia; Injections, Intramuscular; Kidney Failure, Chronic; Leukocytosis; Parathyroid Hormone; Patient Compliance; Peritoneal Dialysis, Continuous Ambulatory; Radiography; Recombinant Proteins; Shoulder Joint | 2002 |
Cross-linked C-terminal telopeptide of type I collagen in serum before and after treatment with alfacalcidol and calcium carbonate in early and moderate chronic renal failure.
Topics: Adult; Aged; Biomarkers; Bone Resorption; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Collagen; Collagen Type I; Female; Humans; Hydroxycholecalciferols; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Peptides | 2002 |
Calcium on trial: beyond a reasonable doubt?
Topics: Acetates; Calcium; Calcium Carbonate; Calcium Compounds; Humans; Hypercalcemia; Kidney Failure, Chronic; Renal Dialysis | 2003 |
RenaGel efficacy in severe secondary hyperparathyroidism.
Topics: Adult; Aged; Aluminum; Aluminum Hydroxide; Calcium; Calcium Carbonate; Chelating Agents; Drug Costs; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Parathyroid Hormone; Patient Selection; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2002 |
The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.
Topics: Aortic Diseases; Arteriosclerosis; C-Reactive Protein; Calcinosis; Calcium; Calcium Carbonate; Disease Progression; Female; Glycoproteins; Humans; Kidney Failure, Chronic; Lipids; Longitudinal Studies; Male; Middle Aged; Osteoprotegerin; Parathyroid Hormone; Phosphorus; Prospective Studies; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Renal Dialysis; Risk Factors | 2003 |
Evaluation of parathyroid hyperplasia by ultrasonographic examination in patients with end-stage renal failure before and at initiation of dialysis.
Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Calcium; Calcium Carbonate; Cholecalciferol; Dialysis; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Ultrasonography, Doppler, Color; Vitamins | 2003 |
Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders.
Topics: Aluminum Hydroxide; Calcium; Calcium Carbonate; Drug Therapy, Combination; Epoxy Compounds; Female; Humans; Kidney Failure, Chronic; Lipids; Magnesium Silicates; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2004 |
Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.
Topics: Antacids; Bone and Bones; Bone Density; Calcium; Calcium Carbonate; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Time Factors | 2005 |
Is 2.5 mEq/L the optimal calcium concentration of dialysate in the use of sevelamer hydrochloride? A study of the dialysate calcium concentration recommended by K/DOQI guidelines.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Calcium Carbonate; Case-Control Studies; Epoxy Compounds; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Vitamin D | 2005 |
Parathyroid hormone and growth in children with chronic renal failure.
Topics: Adolescent; Calcium Carbonate; Child; Child, Preschool; Female; Growth; Humans; Hydroxycholecalciferols; Hypercalcemia; Infant; Kidney Failure, Chronic; Male; Parathyroid Hormone; Puberty; Reference Values | 2005 |
[Zinc and aluminum concentrations in blood of hemodialysis patients and its impact on the frequency of infections].
Topics: Adult; Aged; Aluminum; Calcium Carbonate; Data Interpretation, Statistical; Female; Humans; Infections; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Spectrophotometry, Atomic; Zinc | 2005 |
Introduction to sevelamer hydrochloride and its clinical effects.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Calcium Carbonate; Drug Therapy, Combination; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Renal Insufficiency; Retrospective Studies; Sevelamer | 2005 |
[2 dialysis cases which came to our clinic for the symptoms caused by hypercalcemia].
Topics: Adult; Aged; Calcinosis; Calcium Carbonate; Cardiovascular Diseases; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Renal Dialysis; Vitamin D | 2005 |
Phosphate binders.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Sevelamer | 2006 |
Sevelamer therapy for pediatric end-stage renal disease.
Topics: Calcium; Calcium Carbonate; Female; Humans; Infant; Kidney Failure, Chronic; Phosphorus; Polyamines; Sevelamer | 2006 |
Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
Topics: Acetates; Bicarbonates; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Combinations; Female; Humans; Hypophosphatemia; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer | 2006 |
Lanthanum: new drug. Hyperphosphataemia in dialysis patients: more potential problems than benefits.
Topics: Calcium Carbonate; Chelating Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Europe; Humans; Kidney Failure, Chronic; Lanthanum; Phosphorus Metabolism Disorders; Randomized Controlled Trials as Topic; Renal Dialysis; United States | 2007 |
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer.
Topics: Adult; Aged; Calcinosis; Calcium Carbonate; Cohort Studies; Coronary Artery Disease; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Renal Dialysis; Sevelamer | 2007 |
[Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients].
Topics: Calcium Carbonate; Chelating Agents; Cross-Over Studies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Oxalates; Polyamines; Sevelamer | 2007 |
Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.
Topics: Administration, Oral; Animals; Aortic Diseases; Apolipoproteins E; Calcinosis; Calcium Carbonate; Female; Kidney Failure, Chronic; Mice | 2008 |
Survival in end stage renal disease: calcium carbonate vs. sevelamer.
Topics: Adult; Aged; Calcium Carbonate; Cohort Studies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer | 2007 |
An economic evaluation of sevelamer in patients new to dialysis.
Topics: Antacids; Calcium Carbonate; Chelating Agents; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Markov Chains; Polyamines; Quality-Adjusted Life Years; Renal Dialysis; Sevelamer | 2008 |
Sevelamer.
Topics: Calcium Carbonate; Chelating Agents; Cost Savings; Drug Costs; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Polyamines; Renal Dialysis; Sensitivity and Specificity; Sevelamer; Treatment Outcome; United Kingdom | 2008 |
Use of a balanced low-protein diet in chronic renal failure.
Topics: Acid-Base Equilibrium; Acidosis; Blood Pressure; Blood Urea Nitrogen; Body Weight; Calcium Carbonate; Diet Therapy; Dietary Proteins; Edema; Glomerular Filtration Rate; Hematocrit; Humans; Hyperkalemia; Kidney Failure, Chronic; Serum Albumin | 1967 |
Serum oxalic acid in uremia: effect of a low-protein diet supplemented with essential amino acids and ketoanalogues.
Topics: Amino Acids, Essential; Calcium Carbonate; Creatinine; Dietary Proteins; Female; Humans; Keto Acids; Kidney Failure, Chronic; Male; Oxalates; Oxalic Acid | 1984 |
[Treatment of hyperphosphatemia in chronic renal failure].
Topics: Adolescent; Adult; Aluminum Hydroxide; Calcium Carbonate; Drug Combinations; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Renal Dialysis; Sorbitol | 1984 |
Early treatment of renal osteodystrophy.
Topics: Calcitriol; Calcium; Calcium Carbonate; Carrier Proteins; Chronic Kidney Disease-Mineral and Bone Disorder; Glomerular Filtration Rate; Humans; Hypocalcemia; Kidney Failure, Chronic; Parathyroid Hormone; Phosphate-Binding Proteins; Phosphates | 1984 |
Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
Topics: Administration, Oral; Adult; Aged; Calcitriol; Calcium; Calcium Carbonate; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors; Uremia | 1984 |
[Iatrogenic hypercalcemia in chronic renal failure].
Topics: Adult; Aged; Calcium Carbonate; Female; Humans; Hypercalcemia; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged | 1980 |
Calcium carbonate-induced effects on serum Ca X P product and serum creatinine in renal failure: a retrospective study.
Topics: Acidosis; Calcium; Calcium Carbonate; Calcium, Dietary; Creatinine; Humans; Kidney Failure, Chronic; Phosphates | 1980 |
Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol).
Topics: Adult; Aged; Calcitriol; Calcium; Calcium Carbonate; Creatinine; Dietary Proteins; Female; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Retrospective Studies; Time Factors | 1995 |
Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis.
Topics: Adult; Aluminum; Bone and Bones; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Prospective Studies; Renal Dialysis; Staining and Labeling | 1994 |
Calcitriol and calcium carbonate therapy in early chronic renal failure.
Topics: Calcitriol; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Humans; Kidney Failure, Chronic | 1995 |
Oral calcium carbonate administration ameliorates the progression of renal failure in rats with hypertension.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Calcium Carbonate; Desoxycorticosterone; Doxorubicin; Hydralazine; Hypertension; Kidney Failure, Chronic; Male; Phosphates; Rats; Rats, Wistar; Sodium, Dietary | 1995 |
Calcitriol and calcium carbonate therapy in early chronic renal failure.
Topics: Adult; Alkaline Phosphatase; Bone Density; Calcification, Physiologic; Calcitriol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Female; Humans; Hydroxyproline; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Osteocalcin; Parathyroid Hormone | 1994 |
Treatment of hypercalcaemia with pamidronate in patients with end stage renal failure.
Topics: Calcium Carbonate; Diphosphonates; Female; Humans; Hydroxycholecalciferols; Hypercalcemia; Kidney Failure, Chronic; Male; Middle Aged; Pamidronate; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 1993 |
Treatment of severe secondary hyperparathyroidism with administration of calcium carbonate, intermittent high oral doses of 1,25-dihydroxyvitamin D3 and dialysate with 3 mEq/1 calcium concentration.
Topics: Adult; Calcitriol; Calcium; Calcium Carbonate; Drug Administration Schedule; Female; Hemodialysis Solutions; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Renal Dialysis; Time Factors | 1993 |
Calcium set point progressively worsens in hemodialysis patients despite conventional oral 1-alpha hydroxycholecalciferol supplementation.
Topics: Administration, Oral; Bone Density; Calcium; Calcium Carbonate; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis | 1993 |
Milk-alkali syndrome with metastatic calcification.
Topics: Antacids; Calcinosis; Calcium Carbonate; Calcium, Dietary; Humans; Hypercalcemia; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulatory | 1996 |
Calcitriol and calcium carbonate therapy in early chronic renal failure.
Topics: Antacids; Calcitriol; Calcium Carbonate; Clinical Trials as Topic; Humans; Kidney Failure, Chronic | 1995 |
Low calcium dialysate and hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Combined Modality Therapy; Dialysis Solutions; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Prospective Studies; Risk Factors | 1996 |
The influence of dialysate calcium concentration on the PTH level in children undergoing CAPD.
Topics: Adolescent; Calcium; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Female; Humans; Kidney Failure, Chronic; Male; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Ultrafiltration | 1996 |
[Medical parathyroidectomy. Its efficacy in treatment of lower maxillary brown tumor].
Topics: Administration, Oral; Adult; Calcitriol; Calcium Carbonate; Granuloma, Giant Cell; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Mandibular Diseases; Parathyroid Hormone; Parathyroidectomy; Renal Dialysis | 1996 |
Low doses of calcitriol or calcium carbonate for the prevention of hyperparathyroidism in predialysis patients?
Topics: Calcitriol; Calcium Carbonate; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Parathyroid Hormone; Renal Dialysis | 1996 |
[Life threatening hypercalcemia in a patient with chronic renal failure. Case report].
Topics: Aged; Calcium Carbonate; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Parathyroid Hormone | 1996 |
Effect of CAPD and hemodialysis on parathyroid function.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone and Bones; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Renal Dialysis | 1996 |
The treatment of uremic hyperphosphatemia.
Topics: Calcium Carbonate; Humans; Kidney Failure, Chronic; Phosphates; Phosphorus, Dietary; Renal Dialysis; Uremia | 1996 |
The irritable patient.
Topics: Aggression; Calcium; Calcium Carbonate; Dialysis Solutions; Humans; Hypercalcemia; Irritable Mood; Kidney Failure, Chronic; Male; Medication Errors; Middle Aged; Nurse-Patient Relations; Physician-Patient Relations; Renal Dialysis | 1998 |
Influence of pH on in vitro disintegration of phosphate binders.
Topics: Absorption; Acetates; Administration, Oral; Aluminum Hydroxide; Antacids; Calcium; Calcium Carbonate; Capsules; Chemistry, Pharmaceutical; Forecasting; Gastric Juice; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Secretions; Kidney Failure, Chronic; Phosphates; Solubility; Tablets; Time Factors; Water | 1998 |
Treatment of secondary hyperparathyroidism in hemodialyzed patients with high-dose calcium carbonate without vitamin D3 supplements.
Topics: Administration, Oral; Calcium Carbonate; Cholecalciferol; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis | 1999 |
Effect of low-calcium hemodialysate on bone metabolism.
Topics: Absorptiometry, Photon; Adult; Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density; Calcium; Calcium Carbonate; Cholecalciferol; Female; Hemodialysis Solutions; Humans; Hydroxycholecalciferols; Isoenzymes; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Parathyroid Hormone; Peptide Fragments; Phosphorus; Procollagen; Renal Dialysis | 2000 |
Cost-effectiveness of sevelamer versus calcium carbonate plus atorvastatin to reduce LDL in patients with chronic renal insufficiency with dyslipidemia and hyperphosphatemia.
Topics: Atorvastatin; Calcium Carbonate; Cost-Benefit Analysis; Decision Support Techniques; Epoxy Compounds; Health Care Costs; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Kidney Failure, Chronic; Lipoproteins, LDL; Phosphates; Polyamines; Polyethylenes; Pyrroles; Sevelamer | 2000 |
Trace Metals' abnormalities in hemodialysis patients: relationship with medications.
Topics: Acetates; Aluminum; Aluminum Hydroxide; Cadmium; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Case-Control Studies; Chelating Agents; Chi-Square Distribution; Copper; Cross-Sectional Studies; Erythropoietin; Female; Hematocrit; Humans; Hydroxycholecalciferols; Kidney Failure, Chronic; Lead; Male; Mercury; Metals; Middle Aged; Phosphates; Renal Dialysis; Spectrophotometry, Atomic; Sucralfate; Trace Elements; Zinc | 2000 |
[Iatrogenic hypercalcemia in patients with chronic renal insufficiency].
Topics: Aluminum Hydroxide; Calcium Carbonate; Excipients; Humans; Hypercalcemia; Kidney Failure, Chronic | 1978 |
Effect of oral administration of calcium carbonate, aluminum hydroxide gel and dihydrotachysterol on renal acidosis.
Topics: Acidosis; Administration, Oral; Adolescent; Adult; Aluminum Hydroxide; Calcium; Calcium Carbonate; Dihydrotachysterol; Drug Therapy, Combination; Female; Humans; Kidney Failure, Chronic; Male; Phosphates | 1978 |
Influence of calcium infusion on calcitonin and parathyroid hormone concentrations in normal and hemodialyzed subjects.
Topics: Adult; Calcitonin; Calcium; Calcium Carbonate; Creatinine; Female; Gluconates; Humans; Hypocalcemia; Infusions, Parenteral; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Uremia | 1975 |
CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study.
Topics: Administration, Oral; Adult; Alkaline Phosphatase; Aluminum; Calcium; Calcium Carbonate; Dialysis Solutions; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus | 1992 |
Is calcium carbonate a safe phosphate binder in children with chronic renal failure?
Topics: Adolescent; Calcium; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Peritoneal Dialysis | 1992 |
The effects of calcium carbonate as the sole phosphate binder in combination with low calcium dialysate and calcitriol therapy in chronic hemodialysis patients.
Topics: Alkaline Phosphatase; Calcitriol; Calcium; Calcium Carbonate; Hemodialysis Solutions; Humans; Hypercalcemia; Kidney Failure, Chronic; Parathyroidectomy; Phosphates; Postoperative Period; Renal Dialysis | 1992 |
[Dialysis bone disease associated with other factors].
Topics: Aluminum; Amyloidosis; Bone Diseases, Metabolic; Calcium Carbonate; Deferoxamine; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis | 1992 |
Serum concentrations of calcitriol and PTH in hemo-dialysis patients on treatment with calcium carbonate.
Topics: Adult; Aged; Calcitriol; Calcium Carbonate; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates; Renal Dialysis | 1992 |
Prescription of calcium carbonate to nondialyzed patients with a supranormal serum 1,25(OH)2D3 concentration.
Topics: Calcitriol; Calcium Carbonate; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates | 1991 |
Acute effects of calcium carbonate and citrate on secondary hyperparathyroidism in chronic renal failure.
Topics: Calcium; Calcium Carbonate; Citrates; Citric Acid; Female; Gastric Acidity Determination; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney Failure, Chronic; Male; Middle Aged | 1991 |
[The causes of aluminum cumulation and poisoning in patients with chronic kidney failure treated by hemodialysis on a regular program and the possibilities for therapy].
Topics: Aluminum; Aluminum Hydroxide; Calcium Carbonate; Deferoxamine; Hemodialysis Solutions; Hemofiltration; Humans; Kidney Failure, Chronic; Poisoning; Renal Dialysis; Time Factors | 1991 |
Nutritional state of severe chronic renal failure patients on a low-protein supplemented diet.
Topics: Adolescent; Adult; Aged; Amino Acids, Essential; Blood Proteins; Body Weight; Calcium; Calcium Carbonate; Diet; Dietary Proteins; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Nutrition Disorders; Nutritional Status; Phosphorus; Proteinuria; Urea | 1990 |
Renal osteodystrophy in patients on continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Infant; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory; Rickets | 1990 |
[Use of calcium carbonate (CaCO3) as phosphate binder in dialysis patients in long-term follow-up over 3 years].
Topics: Aluminum; Calcium; Calcium Carbonate; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Long-Term Care; Male; Middle Aged; Phosphates; Renal Dialysis | 1990 |
Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy.
Topics: Bone and Bones; Calcium; Calcium Carbonate; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis; Risk Factors; Vitamin D | 1990 |
Calcium carbonate 1250 mg/1260 mg: an effective phosphate binder.
Topics: Adult; Aged; Calcium Carbonate; Humans; Kidney Failure, Chronic; Middle Aged; Phosphates | 1990 |
Safety and efficacy of calcium carbonate in children with chronic renal failure.
Topics: Adolescent; Calcium Carbonate; Child; Child, Preschool; Female; Glomerular Filtration Rate; Humans; Hypercalcemia; Infant; Kidney Failure, Chronic; Male; Nephrocalcinosis; Safety | 1989 |
The use of calcium carbonate to treat the hyperphosphataemia of chronic renal failure.
Topics: Administration, Oral; Adult; Aged; Aluminum; Bicarbonates; Calcium; Calcium Carbonate; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Renal Dialysis | 1989 |
Identification of calcium oxalate crystals using alizarin red S stain.
Topics: Animals; Anthraquinones; Calcium Carbonate; Calcium Oxalate; Calcium Phosphates; Ethylene Glycol; Ethylene Glycols; Histocytochemistry; Humans; Hydrogen-Ion Concentration; Kidney; Kidney Failure, Chronic; Oxalates; Oxalic Acid; Rats; Rats, Inbred Strains; Solubility; Staining and Labeling | 1985 |
Variable efficacy of calcium carbonate tablets.
Topics: Adult; Biological Availability; Calcium Carbonate; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Tablets; Therapeutic Equivalency | 1989 |
Long-term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism.
Topics: Adult; Aluminum; Calcium; Calcium Carbonate; Dialysis Solutions; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Renal Dialysis; Time Factors | 1989 |
Treatment and prevention of uremic osteodystrophy.
Topics: Amino Acids, Essential; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Vegetarian; Dietary Proteins; Food, Fortified; Humans; Kidney Failure, Chronic; Phosphorus; Renal Dialysis | 1989 |
Effect of phosphate binders on the course of chronic renal failure in rats with focal glomerular sclerosis.
Topics: Aluminum Hydroxide; Animals; Calcium Carbonate; Doxorubicin; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Kidney Failure, Chronic; Male; Proteinuria; Rats; Rats, Inbred Lew | 1989 |
Influence of 1 alpha-hydroxy vitamin D3 (0.25 micrograms/day) and calcium carbonate on patients with chronic renal failure at the predialytic stage.
Topics: Aged; Alkaline Phosphatase; Bicarbonates; Calcium; Calcium Carbonate; Creatinine; Female; Humans; Hydrogen-Ion Concentration; Hydroxycholecalciferols; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates | 1989 |
Management of hyperphosphataemia in renal dialysis patients.
Topics: Adult; Aged; Aluminum Hydroxide; Calcium; Calcium Carbonate; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Renal Dialysis | 1987 |
Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.
Topics: Acetates; Acetic Acid; Adult; Aluminum; Calcium Carbonate; Citrates; Citric Acid; Diet; Humans; Intestinal Absorption; Kidney Failure, Chronic; Kinetics; Phosphorus; Reference Values | 1989 |
Efficacy and safety of long-term treatment with calcium carbonate as a phosphate binder.
Topics: Adult; Aluminum; Aluminum Hydroxide; Blood Chemical Analysis; Calcitriol; Calcium Carbonate; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Long-Term Care; Male; Middle Aged; Phosphates; Renal Dialysis | 1988 |
Long-term suppression of hyperparathyroidism by phosphate binders in uremic children.
Topics: Adolescent; Calcium Carbonate; Child; Child, Preschool; Female; Humans; Hyperparathyroidism; Infant; Infant, Newborn; Kidney Failure, Chronic; Male; Phosphates | 1987 |
Intestinal absorption of oyster shell electrolysate.
Topics: Adult; Animals; Calcium; Calcium Carbonate; Crystallization; Electrolysis; Female; Humans; Hypoparathyroidism; Intestinal Absorption; Kidney Failure, Chronic; Male; Microscopy, Electron, Scanning; Middle Aged; Ostreidae; Postoperative Complications; Rats; Rats, Inbred Strains; Vitamin D Deficiency | 1988 |
[The effects of CaCO3 on renal osteodystrophy--comparison of patients with chronic renal failure in the predialytic stage and patients undergoing maintenance hemodialysis].
Topics: Aged; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis | 1988 |
Influence of antacid administrations on aspirin absorption in patients with chronic renal failure on maintenance hemodialysis.
Topics: Absorption; Adult; Aluminum Hydroxide; Antacids; Aspirin; Calcium Carbonate; Drug Administration Schedule; Drug Combinations; Drug Interactions; Female; Humans; Kidney Failure, Chronic; Magnesium Hydroxide; Male; Middle Aged; Renal Dialysis; Thromboxane B2 | 1988 |
Bone turnover and 1,25-dihydroxycholecalciferol during treatment with phosphate binders.
Topics: Adolescent; Aluminum Hydroxide; Bone Resorption; Calcitriol; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osteogenesis; Phosphates | 1988 |
The approach to the treatment of secondary hyperparathyroidism in early renal failure.
Topics: Calcitriol; Calcium Carbonate; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic | 1988 |
[Aluminum-free phosphate binder in renal failure. Effectiveness and side effects].
Topics: Adult; Aged; Aged, 80 and over; Calcium Carbonate; Calcium Gluconate; Citrates; Citric Acid; Gluconates; Humans; Kidney Failure, Chronic; Middle Aged; Phosphates | 1988 |
[Value of large doses of calcium carbonate for the control of serum level of phosphorus in children with terminal renal failure].
Topics: Adolescent; Calcium Carbonate; Child; Child, Preschool; Female; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus; Renal Dialysis; Terminal Care | 1988 |
Calcium carbonate as an alternative to aluminium hydroxide in maintenance haemodialysis for chronic renal failure.
Topics: Adult; Aluminum Hydroxide; Calcium Carbonate; Female; Humans; Kidney Failure, Chronic; Male; Phosphates; Renal Dialysis | 1987 |
Alternative phosphate binders in dialysis patients: calcium carbonate.
Topics: Aluminum; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Phosphates; Phosphorus; Renal Dialysis | 1986 |
Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis.
Topics: Aluminum Hydroxide; Calcitriol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus; Renal Dialysis | 1987 |
Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis.
Topics: Adult; Aged; Aluminum Hydroxide; Calcium; Calcium Carbonate; Female; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Osteomalacia; Phosphates; Renal Dialysis | 1986 |
[Nutrition of pediatric patients with chronic renal failure].
Topics: Adolescent; Calcium Carbonate; Child; Child, Preschool; Creatinine; Diet, Sodium-Restricted; Dietary Proteins; Energy Intake; Energy Metabolism; Female; Glomerular Filtration Rate; Humans; Infant; Kidney Failure, Chronic; Male; Phosphates; Potassium; Vitamin D; Water-Electrolyte Balance | 1986 |
Management of rachitic deformities in children with chronic renal failure.
Topics: Aluminum Hydroxide; Calcium Carbonate; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Infant; Kidney Failure, Chronic; Male; Radiography; Time Factors | 1986 |
Calcium carbonate as a phosphate binder.
Topics: Calcium Carbonate; Humans; Hypercalcemia; Kidney Failure, Chronic; Phosphates; Renal Dialysis | 1987 |
Oral calcium carbonate as phosphate-binder in infants and children with chronic renal failure.
Topics: Administration, Oral; Calcium Carbonate; Child; Child, Preschool; Female; Humans; Infant; Kidney Failure, Chronic; Male; Phosphates; Renal Dialysis | 1986 |
Calcium carbonate is an effective phosphorus binder in children with chronic renal failure.
Topics: Adolescent; Alkaline Phosphatase; Aluminum Hydroxide; Calcium Carbonate; Child; Child, Preschool; Humans; Hypercalcemia; Infant; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus | 1987 |
Hypercalcaemia after oral calcium-carbonate therapy in patients on chronic haemodialysis.
Topics: Administration, Oral; Adult; Alkaline Phosphatase; Calcium; Calcium Carbonate; Conjunctiva; Eye Diseases; Humans; Hypercalcemia; Intestinal Absorption; Kidney Failure, Chronic; Male; Parathyroid Hormone; Renal Dialysis; Time Factors | 1973 |
[Milk-alkali syndrome and chronic renal failure. (apropos of a case)].
Topics: Acidosis; Age Factors; Aged; Alkalosis; Calcinosis; Calcium Carbonate; Calcium Metabolism Disorders; Conjunctivitis; Duodenal Ulcer; Female; Gastric Juice; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Failure, Chronic; Nephrocalcinosis; Potassium; Uremia; Vitamin D | 1968 |
[Letter: Hypocalcemia in renal insufficiency].
Topics: Aluminum; Calcium Carbonate; Cholecalciferol; Humans; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphates | 1974 |
Serum parathyroid hormone levels and renal handling of phosphorus in patients with chronic renal disease.
Topics: Adult; Aluminum Hydroxide; Animals; Antigens; Calcium; Calcium Carbonate; Cattle; Female; Guinea Pigs; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Radioimmunoassay | 1972 |
The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis.
Topics: Administration, Oral; Alkaline Phosphatase; Aluminum Hydroxide; Biopsy; Bone and Bones; Calcification, Physiologic; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osteomalacia; Phosphorus; Radiography; Renal Dialysis | 1973 |
The contrasting effects on bone histology of vitamin D and of calcium carbonate in the osteomalacia of chronic renal failure.
Topics: Alkaline Phosphatase; Biopsy; Bone Matrix; Calcification, Physiologic; Calcinosis; Calcium; Calcium Carbonate; Calcium Phosphates; Humans; Ilium; Kidney Failure, Chronic; Osteomalacia; Phosphorus; Vitamin D | 1974 |
Calcium carbonate, hypercalcaemia, and peptic ulcer.
Topics: Calcium Carbonate; Humans; Hypercalcemia; Kidney Calculi; Kidney Failure, Chronic; Peptic Ulcer | 1971 |
[Osteodystrophies of chronic uremia].
Topics: Antacids; Bone Diseases; Calcium Carbonate; Humans; Hypocalcemia; Kidney Failure, Chronic; Phosphorus Metabolism Disorders; Renal Dialysis; Uremia; Vitamin D | 1971 |
Comparison of the effect of vitamin D and calcium carbonate in renal osteomalacia.
Topics: Calcium; Calcium Carbonate; Humans; Kidney Failure, Chronic; Osteomalacia; Phosphates; Vitamin D | 1971 |
Calcium carbonate treatment of uremic acidosis.
Topics: Acid-Base Equilibrium; Acidosis; Administration, Oral; Autoanalysis; Calcium; Calcium Carbonate; Creatinine; Glomerular Filtration Rate; Humans; Hydrogen-Ion Concentration; Hypercalcemia; Kidney Failure, Chronic; Kidney Function Tests; Phosphates; Serum Albumin; Urea; Vomiting | 1971 |
The effect of a high intake of calcium carbonate in normal subjects and patients with chronic renal failure.
Topics: Absorption; Adult; Aged; Alkaline Phosphatase; Blood Gas Analysis; Blood Proteins; Calcium; Calcium Carbonate; Creatine; Humans; Kidney Failure, Chronic; Middle Aged; Phosphates; Urea | 1966 |